ArticleFrontiers in gastroenterology (Lausanne, Switzerland)2026
The challenging diagnosis of sinistral portal hypertension in a patient with liver cirrhosis: a case report and literature review.
Article in Frontiers in gastroenterology (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left-sided portal hypertension (LSPH) is commonly associated with pancreatic disease and typically manifests with gastrointestinal bleeding, but not with ascites or hypoalbuminemia. The coexistence of LSPH with liver cirrhosis complicates diagnosis and management, as standard imaging often fails to identify the underlying cause of portal hypertension-related complications. Case presentation: We report a case of a 59-year-old man with decompensated alcohol-related cirrhosis and prior pancreatic surgery, who presented with recurrent gastrointestinal bleeding, severe hypoalbuminemia, and treatment-refractory ascites, all of which persisted despite placement of a transjugular intrahepatic portosystemic shunt (TIPS). Diagnostic work-up included repeated imaging and hemodynamic measurements. Importantly, invasive splenoportography was the only approach that allowed the detection of a hemodynamically significant splenic vein stenosis, and subsequent percutaneous transluminal angioplasty (PTA) led to rapid clinical improvement. Key finding: Standard imaging failed to detect a splenic vein stenosis, which was identified only by invasive phlebography performed via the already placed TIPS. Following PTA, ascites resolved, serum albumin normalized, and no further gastrointestinal bleeding occurred. To our knowledge, this is the first case report describing the full reversal of such a constellation of symptoms after treatment of splenic vein stenosis. Conclusion: This case demonstrates that splenic vein stenosis can cause both hemorrhagic and non-hemorrhagic complications in patients with cirrhosis. Recognition and interventional treatment of LSPH may reverse refractory ascites and hypoalbuminemia, highlighting the importance of high clinical suspicion and invasive evaluation in complex portal hypertension cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.